Data from the United States Surveillance, Epidemiology and End Results Program (SEER) indicate that as of 2014, the 5-year survival rate for children diagnosed with cancer surpassed 85%. 1,2 Improved early survival is accompanied by improvements in late mortality Among 5-year survivors that treated in the 1990s, the 15 year survival rate was 77.1% compared to 57.2% among those treated in the 1970s. 3 Nevertheless, while advances in treatment and supportive care have enhanced survival, survivors of childhood cancer continue to report problems with health status. Survivors are more likely than siblings to report poor general health (13.0% vs. 4.3%), poor mental health (16.3% vs. 10.5%), functional impairments (16.3% vs. 2.9%) and activity limitations (13.7% vs. 4.6%). 4 Survivors also continue to experience chronic health conditions at high frequencies, accumulating an average of 17.1 (95% confidence interval (CI); 16.2-18.1) CTCAE grade 1-5 events and 4.7 (95% CI; 4.6-4.9) grade 3-5 events by age 50 years. 5 This compares to rates among healthy peers of 9.2 (95% CI; 7.9-10.6) for grade 1-5 and 2.3 (95% CI;1.9-2.7) for grade 3-5 chronic conditions. 5 Consequently, current research and clinical care are focused not only on improving the
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Data from the United States Surveillance, Epidemiology and End Results Program (SEER) indicate that as of 2014, the 5-year survival rate for children diagnosed with cancer surpassed 85%. 1,2 Improved early survival is accompanied by improvements in late mortality Among 5-year survivors that treated in the 1990s, the 15 year survival rate was 77.1% compared to 57.2% among those treated in the 1970s. 3 Nevertheless, while advances in treatment and supportive care have enhanced survival, survivors of childhood cancer continue to report problems with health status. Survivors are more likely than siblings to report poor general health (13.0% vs. 4.3%), poor mental health (16.3% vs. 10.5%), functional impairments (16.3% vs. 2.9%) and activity limitations (13.7% vs. 4.6%). 4 Survivors also continue to experience chronic health conditions at high frequencies, accumulating an average of 17.1 (95% confidence interval (CI); 16.2-18.1) CTCAE grade 1-5 events and 4.7 (95% CI; 4.6-4.9) grade 3-5 events by age 50 years. 5 This compares to rates among healthy peers of 9.2 (95% CI; 7.9-10.6) for grade 1-5 and 2.3 (95% CI;1.9-2.7) for grade 3-5 chronic conditions. 5 Consequently, current research and clinical care are focused not only on improving the life-span of survivors but also on improving their long-term health. To achieve this goal, important risk factors and intermediate markers of health, need to be identified. Intermediate markers of health may signal early disease and provide opportunities for intervention. For example, among persons at risk for Type II diabetes, early identification of insulin resistance may trigger either lifestyle or medication interventions. As frailty has been identified as a marker of future morbidity and mortality in aging populations and among childhood cancer survivors, 6, 7 and because there are some interventions that remediate frail health in aging populations, 8 this study will provide preliminary information to design interventions among those who have early indicators of future chronic disease onset . It will also provide information about who in this vulnerable population is most at risk for frailty.
Recent data from the St. Jude Lifetime Cohort Study (mean age 33.6 years, SD 8.1) indicate that chronic disease onset among survivors of childhood cancer may be preceded by frailty, a loss of physiologic reserve similar to that typically seen in older adults. 7 Frailty, described by Fried in the Cardiovascular Health Study, is characterized by three or more of the following: 1) low lean muscle mass, 2) self-reported exhaustion, 3) muscle weakness, 4) slow walking speed, and 5) low energy expenditure. 6 Frailty is prevalent among 9.0% of older adults, 9 7 .8% of young adult childhood cancer survivors, 7 and 8.0% of young adults treated for cancer with hematopoietic stem cell transplant, 10 and is predictive of chronic disease onset and mortality. 11 Among childhood cancer survivors, the prevalence of frailty increases with age, is higher among females, and is associated with radiation exposure and smoking. 7 Although the St. Jude Lifetime Cohort Study analysis evaluates frailty among childhood cancer survivors, and provides important preliminary information about the prevalence of and risk factors for this phenotype, the small sample sizes among specific disease groups make it difficult to identify treatment-related risk factors. 7 The Childhood Cancer Survivor Study has a larger sample size, well characterized treatment exposures and ascertainment of chronic health conditions, providing the opportunity to estimate the direct and indirect effects of treatment-related risk factors (overall and by disease group), baseline sociodemographic risk factors and time varying risky health behaviors on frailty. The availability of the sibling cohort allows us to compare the prevalence of frailty in survivors to that in siblings by strata of age and sex, verifying/extending our findings from the St. Jude Lifetime Cohort to a broader population of childhood cancer survivors, enriched for persons in older age strata. Although the CCSS criteria are completely based on questionnaire data, the questions we have selected closely parallel to Fried 6 and SJLIFE 7 criteria. Appendix 1 describes the specific criteria used to define frailty in the Cardiovascular Health Study, the St Jude Lifetime Cohort Study, and the Childhood Cancer Cohort Survivor Study.
Specific aims:

Specific Aim 1:
To estimate the prevalence of the frailty phenotype among childhood cancer survivors (overall and by disease group) compared to siblings (with additional comparison by age group and sex).
Hypothesis 1:
The prevalence of frailty will be higher among childhood cancer survivors than among siblings.
Specific Aim 2:
To identify associations between sociodemographic factors, chronic conditions, and risky health behaviors and frailty among childhood cancer survivors and siblings.
Hypothesis 2:
Age, female sex, lower educational attainment and lower personal income, chronic condition severity and duration, obesity, smoking, lower physical activity and a combination of heavy alcohol intake are associated with higher risk of frailty.
Specific Aim 3:
To identify the direct and indirect effects of treatment exposures on frailty in childhood cancer survivors.
Hypothesis 3:
Treatment exposures will have a direct effect on frailty. Sociodemographic risk factors, chronic conditions and risky health behaviors will mediate the association between treatment exposures and frailty.
Methods:
Population:
Survivor and sibling members of the CCSS cohort who completed the baseline and follow-up 5 surveys.
Outcome of interest (Dependent variable):
The primary outcome in this study will be the frailty phenotype: we propose to look at the outcome in three mutually exclusive categories (1) Frail; (2) Pre-Frail (3) Non-Frail, using a modification of the Fried frailty criteria. 6 Those with three or more components will be classified as frail, those with two components will be considered pre-frail and those with none or one component, will be considered as not frail. If the number of cases of frailty and pre-frailty are small in subset analyses and/or if associations are similar for these outcomes, we will consider combining pre-frail and frail into one category in the analyses.
Five criteria of frailty phenotype based on FU5 questionnaire: 1. Low lean muscle mass will be defined as either a body mass index (BMI) <18.5 kg/m 2 (LTFU5, item: A1 and A2) or unintentional weight loss of ≥ 10 pounds in past year (LTFU5, item: A3). 2. Self-reported exhaustion: will be defined as a score of ≤40 on the vitality subscale of the short form-36 (SF-36). 12 Specifically, the questions are: How much of the time during the past four weeks (1) did you feel full of life? (LTFU5, ITEM: P1-a) (2) Did you have a lot of energy? (LTFU5, item:P1e) (3) Did you feel worn out? (LTFU5, item:P1-g) (4) Did you feel tired? (LTFU5, item: P1-i). 3. Low energy expenditure: will be defined for males as < 383 kilocalories (kcal) per week and for females as <270 kcal per week, estimated by converting reported frequency and duration of low, moderate and vigorous activities into kilocalories using guidelines provided by the Compendium of Physical Activities 13 (http://sites.google.com/site/compendiumofphysicalactivites). 14 ((LTFU5, items: N15, N16, N17, N18). (LTFU5, items: N15, N19, N20, N21) (LTFU5, items: N22, N23, N24), (LTFU5, ITEM A1)). If the individual reports being physically active, the follow-up questions ask them to report the type of physical activity (vigorous, moderate or light), and duration of physical activity as hours per week (hours/ per week). The compendium of Physical Activities provides estimated (MET) intensity level equivalents for each respective activity performed in various settings noted in the 2013-2014 NHANES. 15 For example, individuals that reported vigorous physical activity for leisure time will have a MET score of 8.0, and those that reported moderate leisure -time physical activity will have a MET score of 4.0. Energy expenditure will be calculated by multiplying the METS (kcal/kg/hour)*weight (kg)*time (hours). 4. Slowness: will be defined as an answer of "Limited for more than three months" to either of two questions: (1) over the last two years, how long has your health limited you in walking uphill or climbing a few flights of stairs; or (2) over the last two years, how long has your health limited you in walking one block. (LTFU5, item: N29-c or e). 5. Weakness: will be defined as an answer of "yes and the condition is still present" to the question:
"Have you ever been told by a doctor or other health care professional that you have, or have had weakness or inability to move arms"? (LTFU5, item: K11).
Covariates (independent variables)
6.3.1. Sociodemographic characteristics:  Age at baseline: Date of survey completion at baseline (Baseline questionnaire) -Date of birth (Baseline questionnaire, item A1).  Age at assessment: it will be defined as Date at the questionnaire interview -Date of birth (Baseline questionnaire, item: A1)).  Sex: Females, Males (Baseline questionnaire. item: A2)  Race: (1) Non-Hispanic white, (2) Non-Hispanic Black, (3) Asian, (4) Hispanic, (5) other (original cohort baseline. Item: A4) or (Expansion cohort baseline item: A5).  Education: categorical variable (1) less than high school, (2) high school graduate (3) college graduate (LTFU5, item: A4).  Employment: categorical variable: (1) Employed or caring for home (2) looking for work or unable to work (3) Student (LTFU5, item: A5).  Annual household income: dichotomous variable: (1) ≥$40,000 per years, (2) <$40,000 per years (LTFU5, item: A9).  Health insurance. (1) Yes /Canadian (2) No (LTFU5, Item: A10).
Health behavior:
 Smoking status: will be defined by number of pack years smoked based on answers to these questions: LTFU5 (2014) items N7-N12. Participants may also be classified for analysis as a never, ever or current smoker depending on the number of missing variables and on the data distribution.  Alcohol use: will be defined as a heavy/risky drinker if the number of drinks for men was five or more drinks per day or 14 drinks per week, and for women four or more drinks per day or seven drinks per week, and categorized as never a heavy drinker, formerly a heavy drinker, or currently a heavy drinker. 16 Conditions will be considered overall and by individual (or combinations of individual) organ system(s). 17 We will include seven categories: cardiac, respiratory, endocrine, subsequent neoplasm, renal, musculoskeletal, neurologic disease. This variable will be continuous, as duration (in years) of having any grade 3-4 chronic condition, and in analyses of specific organ system the duration of a grade 3-4 organ-system specific chronic condition (in years) (LTFU5 (2014), items D1-K15). The most recent chronic condition data will be used for these analyses if the CTCAE data from LTFU5 is not available and the analysis updated when the data are available.
Statistical analysis
Descriptive statistics will be used to characterize the study population for all variables of interest. Table 1 will show frequencies and percentages for categorical variables, and mean and SD for continuous variables.
To compare characteristics between survivors and their siblings, t-tests and chi-square tests will be used as appropriate. For all analyses, sampling weights will be used to account for under-sampling of ALL survivors in the expansion cohort.
For Aim 1, we will calculate the prevalence of each frailty phenotype: 1) pre-frailty (two-components of frailty) 2) and frailty (three-components of frailty) for the overall groups of survivors and siblings and by age group, by sex and, for survivors, by original diagnosis (Tables 2, 3a and 3b). Prevalence comparisons between survivors and siblings, within each group, and across sex-specific age categories (trend) will be conducted using generalized linear models with a log-link function and binomial (or Poisson) error structure and robust variance estimates to account for intra-family correlation. All models will be adjusted or stratified by sex and age.
Aim 2, will explore associations between sociodemographic characteristics (age at each assessment, sex, race/ethnicity, income, employment), risky health behaviors (years of smoking, patterns of heavy drinking, patterns of sedentary behavior), chronic conditions (grade and duration prior to assessment) and frailty phenotype. To accomplish this, we will employ the same model structure utilized in Aim 1. A priori, models will be adjusted for age and sex and the remaining factors examined for inclusion in a final multivariable model depending on their significance and the degree to which they impact other factors in the model. Results will be presented as prevalence ratios with 95% Confidence Intervals. 18, 19 Chronic conditions will be evaluated overall and by organ-system (Tables 4a, 4b and 5 ).
For Aim 3, Structural equation modelling (SEM) 20 will be used to examine a priori hypothesized associations between cancer treatment, subsequent chronic conditions (grade 3-4) and frailty/pre-frailty) . We will evaluate direct and indirect associations between treatment and frailty (via chronic conditions), accounting for both sociodemographic characteristics and risky health behaviors identified in the models above, assuming no-unmeasured confounders. 21 We will present the goodness of fit indices for various models. Chi-square statistics is reported to enable comparisons between the baseline or null model and subsequent revised models. Additionally, the standardized Root Mean Square Residual (SRMR), the Comparative Fit Index (CFI), the Root Mean Square Error of Approximation (RMSEA) and 90% confidence limits. Values for the CFI greater than 0.95 suggest good fit between data and path models, whereas SRMR and RMSEA values less than 0.08 and less than 0.06 respectively suggest good model fit. 22 Figure 1 illustrates our hypothesized causal pathway. Table 6 will inform the SEM, Table 7 will present the final model. :   Tables 1: Demographic Mean(SD) Range + Sampling weights will be applied for all the percentages in this column. 1 The mean of years of smoking will be calculated for individuals that reported that they are current or former smokers, and the standard deviation (SD) of the mean will be reported. ¥ Men: five or more drinks per day or 14 drinks per week; women: four or more drinks per day or seven drinks per week. $$ Sedentary behavior: where no physical activity reported or irregular physical activity (i.e. fewer than three times per week and or/less than 20 minutes per sessions). where no physical activity reported or irregular physical activity (i.e. fewer than three times per week and or/less than 20 minutes per sessions). ++ For the Duration of chronic condition, we will conduct any chronic condition, in separate models than organ system specific chronic condition. . + Sampling weights will be applied for all the percentages in this column. ¥ Men: five or more drinks per day or 14 drinks per week; women: four or more drinks per day or seven drinks per week. $$ Sedentary behavior: where no physical activity reported or irregular physical activity (i.e. fewer than three times per week and or/less than 20 minutes per sessions). ++ For the Duration of chronic condition, we will conduct any chronic condition, separate than organ system specific chronic condition. 
Examples of Tables
13
Slowness
Women <159 cm tall and men <173 were classified as slow if they took ≥7 seconds to walk 15 feet at their usual pace; and women ≥159 cm tall and men ≥ 173 cm tall were classified as slow if they took ≥6 seconds to walk 15 feet at their usual pace "Limited for more than 3 months" to either of two questions: (1) over the last 2 years, how long has your health limited you in walking uphill or climbing a few flights of stairs; or (2) over the last 2 years, how long has your health limited you in walking one block Weakness
Hand-grip strength stratified by body mass index and sex 
